Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to learn more. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Rachel Slattery

Director, Events Strategy

Rachel Slattery serves as the Director of Event Strategy for NephCure. Before joining the team in May 2019, she started her career in the event planning industry at the Chamber of Commerce for Greater Philadelphia and has experience coordinating small to large scale events of all types from start to finish. Rachel is passionate about turning events into unforgettable experiences and helping others along the way. In her spare time, she loves to travel, hike and spend time with her Maltipoo dog, Peanut!

King of Prussia, PA

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.